Inyx Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2001
2002
2003
2004
2005
Sales/Revenue
83.70
54.50
13,099.00
15,699.00
49,565.00
Cost of Goods Sold (COGS) incl. D&A
149.90
142.20
11,021.00
15,101.00
39,529.00
Gross Income
66.20
87.70
2,078.00
598.00
10,036.00
SG&A Expense
24.00
8.60
6,510.00
12,837.00
30,986.00
Unusual Expense
-
-
4,166.00
-
-
Non Operating Income/Expense
8.10
16.80
4,680.00
-
-
Interest Expense
-
-
491.00
3,370.00
10,059.00
Pretax Income
82.10
113.10
13,769.00
15,609.00
31,009.00
Income Tax
-
-
1,294.00
1,333.00
-
Consolidated Net Income
82.10
113.10
12,475.00
16,942.00
31,009.00
Net Income
82.10
113.10
12,475.00
16,942.00
31,009.00
Net Income After Extraordinaries
82.10
113.10
12,425.00
16,942.00
31,009.00
Net Income Available to Common
82.10
113.10
12,475.00
16,942.00
31,009.00
EPS (Basic)
0.02
0.02
0.55
0.52
0.78
Basic Shares Outstanding
5,000.00
5,000.00
22,857.30
32,598.40
39,774.50
EPS (Diluted)
0.02
0.02
0.55
0.52
0.78
Diluted Shares Outstanding
5,000.00
5,000.00
22,857.30
32,598.40
39,774.50
EBITDA
70.50
74.20
4,045.00
11,454.00
16,280.00

About Inyx

View Profile
Address
825 Third Avenue
New York New York 10022
United States
Employees -
Website -
Updated 07/08/2019
Develops & manufactures pharmaceuticals .